Talis Biomedical (TLIS) Stock Price, News & Analysis

Company Overview

Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

Key Stats

• Today's Range: $1.74 to $1.74
• 50-Day Range: $1.57 to $1.90
• 52-Week Range: $1.37 to $9.60
• Volume: 1 shs
• Average Volume: 3,442 shs
• Market Capitalization: $3.17 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TLIS Stock Analysis - Frequently Asked Questions

How have TLIS shares performed this year?

Talis Biomedical's stock was trading at $1.7590 at the beginning of the year. Since then, TLIS shares have decreased by 1.1% and is now trading at $1.74.
View the best growth stocks for 2025 here.

How were Talis Biomedical's earnings last quarter?

Talis Biomedical Co. (NASDAQ:TLIS) announced its earnings results on Tuesday, March, 15th. The company reported ($18.90) EPS for the quarter, topping the consensus estimate of ($19.20) by $0.30.

When did Talis Biomedical's stock split?

Shares of Talis Biomedical reverse split on Thursday, July 6th 2023. The 1-15 reverse split was announced on Thursday, July 6th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 6th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Talis Biomedical IPO?

Talis Biomedical (TLIS) raised $150 million in an initial public offering (IPO) on Friday, February 12th 2021. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan, BofA Securities and Piper Sandler served as the underwriters for the IPO and BTIG was co-manager.

How do I buy shares of Talis Biomedical?

Shares of TLIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Talis Biomedical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Talis Biomedical investors own include Bloom Energy (BE), SoFi Technologies (SOFI), Athenex (ATNX), Alkaline Water (WTER), Milestone Scientific (MLSS), TherapeuticsMD (TXMD) and Affirm (AFRM).

Company Calendar

• Last Earnings: 3/15/2022
• Today: 4/02/2025
• Next Earnings (Estimated): 5/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Analytical instruments
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NASDAQ:TLIS
• CIK: 1584751
• Web: talis.bio
• Phone: 650-433-3000
• Fax: N/A
• Employees: 260
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($28.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-62,010,000.00
• Net Margins: N/A
• Pretax Margin: -12,506.37%
• Return on Equity: -79.74%
• Return on Assets: -57.16%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 7.76
• Quick Ratio: 7.76

Sales & Book Value

• Annual Sales: $300,000.00
• Price / Sales: 10.57
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $37.95 per share
• Price / Book: 0.05

Miscellaneous

• Outstanding Shares: 1,823,000
• Free Float: 984,000
• Market Cap: $3.17 million
• Optionable: No Data
• Beta: 1.47